Invention Grant
- Patent Title: siRNA knocking down human PD-1 and recombinant expression CAR-T vector and their construction methods and applications
-
Application No.: US16331147Application Date: 2017-11-13
-
Publication No.: US11242530B2Publication Date: 2022-02-08
- Inventor: Lei Yu , Liqing Kang , Zhou Yu
- Applicant: SHANGHAI UNICAR-THERAPY BIO-MEDICINE TECHNOLOGY CO., LTD
- Applicant Address: CN Shanghai
- Assignee: SHANGHAI UNICAR-THERAPY BIO-MEDICINE TECHNOLOGY CO., LTD
- Current Assignee: SHANGHAI UNICAR-THERAPY BIO-MEDICINE TECHNOLOGY CO., LTD
- Current Assignee Address: CN Shanghai
- Agency: Bayramoglu Law Offices LLC
- Priority: CN201611123283.4 20161208
- International Application: PCT/CN2017/110653 WO 20171113
- International Announcement: WO2018/103501 WO 20180614
- Main IPC: C12N15/113
- IPC: C12N15/113 ; C12N15/86 ; A61K35/17 ; C12N15/66 ; C07K14/705

Abstract:
Provided are a human PD-1 knockdown siRNA, a recombinant expression CAR-T vector, a preparation method thereof, and an application of the same. A PD-1 knockdown siRNA expression cassette and an siRNA expression product thereof can be applied to a CAR-T therapy of multiple myeloma (MM) for eliminating or alleviating a tumor immune escape mechanism, and in the suppression of an immune escape mechanism in a CAR-T therapy of a tumor, such as pancreatic cancer, brain glioma, and myeloma.
Public/Granted literature
Information query
IPC分类: